International Journal of COPD,
Journal Year:
2023,
Volume and Issue:
Volume 18, P. 2825 - 2837
Published: Nov. 1, 2023
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
progressive
resulting
in
range
of
symptoms
including
breathlessness.
"Symptom
burden"
describes
the
severity
and
impact
multiple
an
individual
best
quantified
using
validated
symptom
instruments
but
not
routinely
measured
clinical
practice.
Therefore,
we
wanted
to
assess
overall
burden
patients
with
moderate-to-severe
COPD
find
associated
independent
predictors.A
single-centre
cross-sectional
study
who
attended
Westmead
Breathlessness
Service
between
March
2017
May
2022
was
conducted.
We
obtained
baseline
demographic
data,
lung
function,
assessed
quality
life
(CAT),
anxiety/depression
(HADS),
(CMSAS).
compared
variables
men
women
unpaired
t
tests
or
Mann-Whitney
for
continuous
variables,
Fisher's
exact
categorical
variables.
used
regression
look
predictors
burden.
Data
were
analysed
Stata/IC
15.1.Eighty-nine
COPD,
mean
age
72.6
years,
55%
male,
FEV1
32%
predicted,
reported
average
8.9
6.9
physical
1.6
psychological
symptoms.
The
most
common
shortness
breath
(100%)
lack
energy
(80%),
worrying
(65%)
feeling
anxious
(61%).
Median
CMSAS
total
score
higher
than
(1.34
versus
1.04,
respectively;
p=0.03)
more
experiencing
nervousness
(p=0.011)
anxiety
(p=0.005).
Female
sex
(p=0.003),
HADS-Anxiety
(p=0.0001),
HADS-Depression
(p=0.0001)
independently
linear
model
explained
63%
variability.Very
high
exists
among
severe
COPD.
Anxiety,
depression,
female
increasing
Identifying
understanding
differences
symptoms,
interventions
targeting
depression
may
help
reduce
within
this
population.
Frontiers in Neuroscience,
Journal Year:
2023,
Volume and Issue:
17
Published: April 18, 2023
Recent
changes
in
cannabis
accessibility
have
provided
adjunct
therapies
for
patients
across
numerous
disease
states
and
highlights
the
urgency
understanding
how
cannabinoids
endocannabinoid
(EC)
system
interact
with
other
physiological
structures.
The
EC
plays
a
critical
modulatory
role
respiratory
homeostasis
pulmonary
functionality.
Respiratory
control
begins
brainstem
without
peripheral
input,
coordinates
preBötzinger
complex,
component
of
ventral
group
that
interacts
dorsal
to
synchronize
burstlet
activity
drive
inspiration.
An
additional
rhythm
generator:
retrotrapezoid
nucleus/parafacial
drives
active
expiration
during
conditions
exercise
or
high
CO2.
Combined
feedback
information
from
periphery:
through
chemo-
baroreceptors
including
carotid
bodies,
cranial
nerves,
stretch
diaphragm
intercostal
muscles,
lung
tissue,
immune
cells,
our
can
fine
tune
motor
outputs
ensure
we
oxygen
necessary
survive
expel
CO2
waste
produce,
every
aspect
this
process
be
influenced
by
system.
expansion
access
potential
therapeutic
benefits,
it
is
essential
investigations
continue
uncover
underpinnings
mechanistic
workings
It
imperative
understand
impact
cannabis,
exogenous
on
these
systems,
some
compounds
mitigate
depression
when
combined
opioids
medicinal
therapies.
This
review
perspective
central
versus
functionality
behaviors
will
summarize
literature
available
organic
synthetic
breathing
has
shaped
homeostasis.
Finally,
look
at
future
applications
offer
treatment
diseases
possible
expanding
safety
profile
opioid
while
preventing
overdose
fatalities
result
arrest
persistent
apnea.
Biology of Sex Differences,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: June 15, 2023
Abstract
Background
Sex
and
gender
impacts
health
outcomes
disease
risk
throughout
life.
The
of
women
members
the
Two-Spirit,
Lesbian,
Gay,
Bisexual,
Transgender,
Queer
or
Questioning
(2S/LGBTQ
+)
community
is
often
compromised
as
they
experience
delays
in
diagnosis.
Distinct
knowledge
gaps
these
populations
have
prompted
funding
agencies
to
mandate
incorporation
sex
into
research.
Sex-
gender-informed
research
perspectives
methodology
increases
rigor,
promotes
discovery,
expands
relevance
Thus,
Canadian
Institutes
Health
Research
(CIHR)
implemented
a
gender-based
analysis
(SGBA)
framework
recommending
inclusion
SGBA
project
proposals
2010
then
mandating
grant
2019.
To
examine
whether
this
resulted
increased
mention
funded
abstracts,
we
searched
publicly
available
database
abstracts
by
CIHR
analyze
percentage
that
mentioned
population
be
studied
better
understand
broader
equity
issues
also
examined
either
female-specific
within
2S/LGBTQ
+
community.
Results
We
categorized
total
8,964
Project
Operating
awarded
from
2009
2020
based
on
their
study
gender.
Overall,
under
3%
explicitly
and/or
gender,
1.94%
sex,
0.66%
As
one
goals
inform
understudied
with
respect
SGBA,
found
5.92%
outcomes,
0.35%
focused
Conclusions
Although
there
was
an
number
grants
across
time,
were
less
than
2%
between
2020.
mentioning
differences
did
not
change
significantly
over
time.
dollars
allocated
which
substantially
2020,
increasing
1.26%
3.47%,
respectively,
decreasing
0.49%
no
for
+-specific
health.
Our
findings
suggest
more
work
needs
done
ensure
public
can
evaluate
what
will
advance
awareness
Texas Heart Institute Journal,
Journal Year:
2023,
Volume and Issue:
50(4)
Published: Aug. 11, 2023
Abstract
Background
The
study
aimed
to
review
differences
in
the
presentation
and
outcomes
of
acute
pulmonary
embolism
(PE)
between
men
women.
Methods
PubMed,
CENTRAL,
Web
Science,
Embase
were
searched
for
studies
comparing
clinical
features
or
PE
Baseline
comorbidities,
risk
factors,
features,
mortality
rates
also
compared
Results
Fourteen
included.
It
was
noted
that
presented
with
at
a
statistically
significantly
younger
age
than
women
(
P
<
.001).
Smoking
history
.001),
lung
disease
=
.004),
malignancy
.02),
unprovoked
.004)
more
frequent
among
There
no
difference
sexes
hypertension,
diabetes,
recent
immobilization.
A
higher
proportion
chest
pain
.02)
hemoptysis
whereas
syncope
.005)
Compared
men,
had
high-risk
.003).
use
thrombolytic
therapy
inferior
vena
cava
filter.
Neither
crude
nor
adjusted
different
Conclusion
This
found
presentation,
symptoms
differed
Limited
data
suggest
frequently
but
did
not
differ
2
sexes.
Importantly,
both
show
rate
International Journal of COPD,
Journal Year:
2023,
Volume and Issue:
Volume 18, P. 2825 - 2837
Published: Nov. 1, 2023
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
progressive
resulting
in
range
of
symptoms
including
breathlessness.
"Symptom
burden"
describes
the
severity
and
impact
multiple
an
individual
best
quantified
using
validated
symptom
instruments
but
not
routinely
measured
clinical
practice.
Therefore,
we
wanted
to
assess
overall
burden
patients
with
moderate-to-severe
COPD
find
associated
independent
predictors.A
single-centre
cross-sectional
study
who
attended
Westmead
Breathlessness
Service
between
March
2017
May
2022
was
conducted.
We
obtained
baseline
demographic
data,
lung
function,
assessed
quality
life
(CAT),
anxiety/depression
(HADS),
(CMSAS).
compared
variables
men
women
unpaired
t
tests
or
Mann-Whitney
for
continuous
variables,
Fisher's
exact
categorical
variables.
used
regression
look
predictors
burden.
Data
were
analysed
Stata/IC
15.1.Eighty-nine
COPD,
mean
age
72.6
years,
55%
male,
FEV1
32%
predicted,
reported
average
8.9
6.9
physical
1.6
psychological
symptoms.
The
most
common
shortness
breath
(100%)
lack
energy
(80%),
worrying
(65%)
feeling
anxious
(61%).
Median
CMSAS
total
score
higher
than
(1.34
versus
1.04,
respectively;
p=0.03)
more
experiencing
nervousness
(p=0.011)
anxiety
(p=0.005).
Female
sex
(p=0.003),
HADS-Anxiety
(p=0.0001),
HADS-Depression
(p=0.0001)
independently
linear
model
explained
63%
variability.Very
high
exists
among
severe
COPD.
Anxiety,
depression,
female
increasing
Identifying
understanding
differences
symptoms,
interventions
targeting
depression
may
help
reduce
within
this
population.